Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients

Indian Journal of Pathology and Microbiology

Volumn 39, Issue 1, 1996, Pages 5-12

  Aziz, Mehar ^a   Malik, Abida ^a   Abbas, S M Shakeel ^a   Vasenwala, Shaista ^a   Kalam, Abul ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Cell mediated immunity (CMI); Leprosy

Indexed keywords

LEPROMIN;

ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CHILD; FEMALE; HUMAN; IMMUNOLOGY; LEPROSY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; IMMUNITY, CELLULAR; LEPROMIN; LEPROSY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTE SUBSETS;

EID: 0029692640     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Rea TH, Levan NE : Current concepts in the immunology of leprosy. Arch Dermatol. 113: 345-353, 1977.
2. Gonzalez-Amaro E, Baranda L, Abud-Mendoza C et al : Quantitative analysis of contra-suppressor T-lymphocytes in leprosy. Induction of Ia antigens with gamma interferon. Int. J. Leprosy. 55: 651-654, 1987.
3. Stach JL, Strobel M, Fumoux F, Bach JF : Defect in generation of cyiotoxic T-cells in lepromatous leprosy. Clin Exp. Immunol. 48: 633-640, 1982.
4. Reinherz EL, Schlossman SF : The differentiation and function of human T-lymphocytes. Cell 18:821-827, 1980.
5. Mehra V, Convit J, Rubinstein A, Bloom BR : Activated suppressor T cells in leprosy. J. Immunol. 129: 1946-1951, 1982.
6. Rea TH, Bakke AC, Parker JW, Modlin RL, Horwitz DA : Peripheral blood T-lymphocytes subsets in leprosy. Int. J. Leprosy. 52 :311-317, 1984.
7. Myrvang B, Godal T, Ridley DS, Froland SS, Song YK : Immune responsiveness to M. leprae and other mycobacterial antigens through-out the clinical and histopathological spectrum of leprosy. Clin. Exp. Immunol. 14 : 541-553, 1973.
8. Narayanan RB, Girdhar BK, Desikan KV : OKT6 + Langerhans cell numbers in DNCB reactions among leprosy patients. Int. J. Leprosy 54 : 423-426, 1986.
9. Sivamani S, Garg BR, Lal B : Quantitative DNCB epicutaneous sensitization in leprosy patients and controls. Lepr. India. 53 : 45-51, 1981.
10. Strickland NH : The influence of imrnunosuppression and immunodeficiency of infections with leprosy and tuberculosis (Editorial). Int. J. Leprosy 53: 86-100, 1985.
11. Dharmendra : Studies of lepromin test. The active principal of lepromin is a protein antigen of the bacillus. Lepr. India. 13: 89-103, 1941.
12. Desikan KV, Mukherjee A, Ramu G, Tiwari VD : Sequential histological study of lepromin reactions. Int. J. Lepr. 51: 473-480, 1983.
13. Mitsuda K : On the values of a skin reaction to suspension of leprous nodules. Jpn. J. Dermatol. Urol. 19: 697-708, 1919.
14. Thomas J, Joseph M, Ramanujam K, Chacko CJG, Job CK : Histology of Fernandez reaction. An appraisal. Int. J. Leprosy, 49: 1-8, 1981.
15. Sengupta U, Ganapati R, Garg BR, Ghosh M, Desikan KV : Evaluation of standard Dharmendra lepromin. Indian J. of Leprosy 56: 748-753, 1984.
16. Lyer CGS, Desikan KV : Nerve involvement in leprosy. Pathogenesis and significance. Neurology. 16: 89-92, 1968.
17. Dharmendra, Chatterjee SN : Maculoanaesthetic leprosy. Its diagnosis and classification. Lepr. India. 33: 106-109, 1962.
18. Price MA, Anders EM, Anders RF, Russell DA, Dennis ES : Cell mediated immunologic status of healthy members of families with a history of leprosy. Int. J. Leprosy. 43: 307-313, 1975.
19. Laal S, Mishra RS, Nath I : Type 1 reactions in leprosy - Heterogeneity in T-cell functions related to the background leprosy type. Int. J. Leprosy 55: 481-493, 1987.
20. Miller RA, Shen J, Rea TH, Harnisch JP : Treatment of chronic erythema nodosum leprosum with cyclosporin A produces clinical and immunohistologic remission. Int. J. Leprosy 55: 441-449, 1987.
21. Manimakalai, Bhatia VN, Balakrishnan S, Shanmugham N : E-rosettes in leprosy patients. Leprosy India. 54: 685-689, 1982.
22. Wybran T, Dupont E : The active E-rosette. An early marker for T-cell' activation. Ann. Immunol. (Inst. Pasteur). 133: 211-218, 1982.
23. Waldorf DS, Sheagren JN, Trautman JR, Block JB : Impaired delayed hy-persensitivity in patients with lepromatous leprosy. Lancet, 2: 773-776, 1966.
24. Klenerman P : Etiological factors in delayed type hypersensitivity reactions in leprosy (Editorial). Int. J. Leprosy 55: 702-707, 1986.
25. Ridley DS : Histological classification and the immunological spectrum of leprosy. Bull. WHO, 51: 451-465, 1974.
26. Ridley DS, Jopling WH : Classification of leprosy according to immu-nity. A five group system. Int. J. Leprosy 34: 255-273, 1966.
27. Ridley DS, Waters MFW : Significance of variations within the lepromatous group. Leprosy Rev. 40: 143-152, 1969.
28. Culling CFA. Handbook of histopathological and histochemical techniques. IIIr d. Butterworths and Co. Ltd., London. 1974: Chapter 18, 397. "Wade-Fite technique for M. Leprae in paraffin sections (modified)"